Evidence map›Paper›PMID 35695527›Full record

ArticlemSphere2022

Monocyte Transcriptional Responses to Mycobacterium tuberculosis Associate with Resistance to Tuberculin Skin Test and Interferon Gamma Release Assay Conversion.

Jason D Simmons, Kimberly A Dill-McFarland, Catherine M Stein, Phu T Van, Violet Chihota, Thobani Ntshiqa, Pholo Maenetje, Glenna J Peterson, Penelope Benchek, Mary Nsereko and 9 more

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Frontiers in immunology · 2024
    Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 4 countries.

Jason D SimmonsTB Research & Training Center, Department of Medicine, University of Washingtongrid.34477.33, Seattle, Washington, USA.ORCID 0000-0002-7669-2803
Kimberly A Dill-McFarlandTB Research & Training Center, Department of Medicine, University of Washingtongrid.34477.33, Seattle, Washington, USA.
Catherine M SteinDepartment of Population & Quantitative Health Sciences, Case Western Reserve Universitygrid.67105.35, Cleveland, Ohio, USA.
Phu T VanFred Hutchinson Cancer Research Centergrid.270240.3, Seattle, Washington, USA.
Violet ChihotaSchool of Public Health, University of Witwatersrand, Johannesburg, South Africa.
Thobani NtshiqaThe Aurum Institutegrid.414087.e, Parktown, South Africa.
Pholo MaenetjeThe Aurum Institutegrid.414087.e, Parktown, South Africa.
Glenna J PetersonTB Research & Training Center, Department of Medicine, University of Washingtongrid.34477.33, Seattle, Washington, USA.
Penelope BenchekDepartment of Population & Quantitative Health Sciences, Case Western Reserve Universitygrid.67105.35, Cleveland, Ohio, USA.
Mary NserekoUganda-CWRU Research Collaboration, Kampala, Uganda.
Kavindhran VelenThe Aurum Institutegrid.414087.e, Parktown, South Africa.
Katherine L FieldingSchool of Public Health, University of Witwatersrand, Johannesburg, South Africa.
Alison D GrantSchool of Public Health, University of Witwatersrand, Johannesburg, South Africa.
Raphael GottardoFred Hutchinson Cancer Research Centergrid.270240.3, Seattle, Washington, USA.
Harriet Mayanja-KizzaDepartment of Medicine, School of Medicine, Makerere University, Kampala, Uganda.
Robert S WallisThe Aurum Institutegrid.414087.e, Parktown, South Africa.
Gavin ChurchyardSchool of Public Health, University of Witwatersrand, Johannesburg, South Africa.
W Henry BoomDepartment of Medicine, Case Western Reserve Universitygrid.67105.35, Cleveland, Ohio, USA.
Thomas R HawnTB Research & Training Center, Department of Medicine, University of Washingtongrid.34477.33, Seattle, Washington, USA.
Aurum Institute · ZAUniversity of the Witwatersrand · ZAUniversity of Washington · USCase Western Reserve University · USFred Hutch Cancer Center · USInfectious Diseases Research Collaboration · UGMakerere University · UGSIB Swiss Institute of Bioinformatics · CH

Funding

IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)75N93019C00071 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI FORTUNE, SARAH · 2019 to 2025
$57.3M
HOST DEFENSE TRAINING IN ALLERGY AND INFECTIOUS DISEASEST32AI007044 · NIAID · UNIVERSITY OF WASHINGTON · PI DAVID Neal FREDRICKS · 1985 to 2026
$14.6M
Resistance to MTB infection in HIV infected individuals in Uganda and S. AfricaR01AI124348 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BOOM, W. HENRY, HAWN, THOMAS R · 2016 to 2020
$11.3M
Aurum Clinical Trials UnitUM1AI154463 · NIAID · AURUM INSTITUTE NPC · PI Gavin John Churchyard · 2021 to 2026
$8.1M
Seattle Tuberculosis Research Advancement CenterP30AI168034 · NIAID · UNIVERSITY OF WASHINGTON · PI CHETAN SESHADRI · 2022 to 2026
$6.3M
Natural Resistance to Mycobacterium Tuberculosis InfectionU01AI115642 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BOOM, W. HENRY, MAYANJA-KIZZA, HARRIET · 2015 to 2019
$3.5M
Epigenetic & Post-Translational Mechanisms of Macrophage Resistance to Mycobacterium tuberculosis During HIV Co-InfectionR33AI138272 · NIAID · UNIVERSITY OF WASHINGTON · PI BOOM, W. HENRY, HAWN, THOMAS R · 2020 to 2022
$3.4M
Macrophages and Resistance to Mycobacterium Tuberculosis Infection in HumansK08AI143926 · NIAID · UNIVERSITY OF WASHINGTON · PI SIMMONS, JASON · 2019 to 2023
$951k
Pulmonary Innate Immunity & Resistance to Mycobacterium Tuberculosis InfectionK24AI137310 · NIAID · UNIVERSITY OF WASHINGTON · PI HAWN, THOMAS R · 2018 to 2022
$892k
Medical Research Council MR/R010161/1NIAID NIH HHS 75N93019C00071NIAID NIH HHS K08 AI143926NIAID NIH HHS K24 AI137310NIAID NIH HHS N01 AI070022NIAID NIH HHS P30 AI168034NIAID NIH HHS R01 AI124348NIAID NIH HHS R33 AI138272NIAID NIH HHS T32 AI007044NIAID NIH HHS U01 AI115642NIAID NIH HHS UM1 AI154463
6 · The paper itself

Abstract

Heavy exposure to Mycobacterium tuberculosis, the etiologic agent of tuberculosis (TB) and among the top infectious killers worldwide, results in infection that is cleared, contained, or progresses to disease. Some heavily exposed tuberculosis contacts show no evidence of infection using the tuberculin skin test (TST) and interferon gamma release assay (IGRA); yet the mechanisms underlying this "resister" (RSTR) phenotype are unclear. To identify transcriptional responses that distinguish RSTR monocytes, we performed transcriptome sequencing (RNA-seq) on monocytes isolated from heavily exposed household contacts in Uganda and gold miners in South Africa after

Indexed as

Latent TuberculosisMycobacterium tuberculosisTuberculosisHumansInterferon-gamma Release TestsMonocytesTuberculin Testhost-pathogen interactionsinnate immunityMycobacterium tuberculosisRNAsequence analysistranscriptometumor necrosis factor alpha

Identifiers

PMID35695527
PMCPMC9241521
OpenAlexW4282825157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.